本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR
SABBY MANAGEMENT, LLC (CIK 1535610) reported $110.5M across 16 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: SPY ($54.1M, 48.99%), SPY ($15.3M, 13.85%), SOXX ($13.3M, 12.02%), SOXX ($13.2M, 11.99%), SPY ($4.1M, 3.72%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SPY | STATE STREET SPDR S&P | $54.1M | 48.99% | 725 | Added |
| 2 | SPY | STATE STREET SPDR S&P | $15.3M | 13.85% | 205 | New |
| 3 | SOXX | ISHARES RUSSELL | $13.3M | 12.02% | 442 | New |
| 4 | SOXX | ISHARES RUSSELL | $13.2M | 11.99% | 441 | Added |
| 5 | SPY | STATE STREET SPDR S&P | $4.1M | 3.72% | 5,500 | Added |
| 6 | TOYO | TOYO CO LTD | $3.5M | 3.17% | 503,846 | New |
| 7 | ABVX | ABIVAX SA | $1.1M | 0.99% | 82 | Added |
| 8 | FAMI | FARMMI INC | $840,307 | 0.76% | 3.5M | New |
| 9 | SIDU | SIDUS SPACE INC | $816,305 | 0.74% | 2,905 | Added |
| 10 | CRVO | CERVOMED INC | $771,528 | 0.70% | 248,880 | New |
| 11 | ZVRA | ZEVRA THERAPEUTICS | $612,318 | 0.55% | 427 | Added |
| 12 | PAVS | PARANOVUS ENTERTNMNT TECH LT | $560,519 | 0.51% | 75,440 | New |
| 13 | TPST | TEMPEST THERAPEUTICS INC | $567,527 | 0.51% | 511,286 | Added |
| 14 | BIAF | BIOAFFINITY TECHNOLOGIES | $296,905 | 0.27% | 365,647 | New |
| 15 | BCTX | BRIACELL THERAPEUTICS CORP | $261,536 | 0.24% | 80,721 | Added |
| 16 | CREG | SMART POWER CORP | $263,214 | 0.24% | 127,774 | New |
| 17 | REVB | REVELATION BIOSCIENCES INC | $216,899 | 0.20% | 210,582 | Added |
| 18 | SNES | SENESTECH INC | $211,216 | 0.19% | 141,756 | Trimmed |
| 19 | BCTXL | BRIACELL THERAPEUTICS CORP | $169,441 | 0.15% | 190,383 | Trimmed |
| 20 | SIDU | SIDUS SPACE INC | $121,889 | 0.11% | 43,377 | New |
| 21 | INM | INMED PHARMACEUTICALS | $69,704 | 0.06% | 44,970 | Trimmed |
| 22 | NUWE | NUWELLIS INC | $49,935 | 0.05% | 16,372 | New |
| 23 | BCTXZ | BRIACELL THERAPEUTICS CORP | $11,464 | 0.01% | 120,802 | Trimmed |
| 24 | ALP | ALPHATON CAPITAL CORP | $0 | 0.00% | 0 | Exited |
| 25 | BDRX | BIODEXA PHARMACEUTICALS PLC | $0 | 0.00% | 0 | Exited |
来源：SEC 13F 申报文件 · 截至 2026-06-30